03.14.25 -- Developing Bespoke Antisense Oligonucleotides To Treat Rare Diseases

Cell banking stands at the forefront of medical advancement. This guide delves into the steps involved in protecting these priceless resources, from cell collection and processing to storage and cell expansion.

Learn about new materials being considered for single-use cold chain storage containers to reduce or eliminate issues with durability at cold temperatures.

Explore a structured solution to automate the Legally Authorized Representative (LAR) workflow, ensuring that consent, reconsent, and assessments are accurately documented and compliant with regulations.

Rare disease innovation demands robust channel strategies for patient access. Learn how a patient-centric approach, logistical solutions, and strong partnerships are key to successful patient access.

Stem cell therapy has already revolutionized the field of oncology. But where do we go from here? Dr. Robert S. Negrin addresses three key areas of CAR T-cell therapy on the brink of innovation.

Direct outreach to potential participants and communication with their healthcare providers is key to boosting trial awareness and participation, thereby achieving recruitment targets.

To develop and execute a successful clinical strategy, trial sponsors must be able to rapidly acquire detailed data insights. Learn how you can better utilize your trial data and achieve greater insights.